1. Pera J, Dziedzic T, Adamski M, Jagiełła J, Krupa M, Moskala M, Szczudlik A, Słowik A.
   Interleukin 6-174G>C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case-control study and meta-analysis.
   Acta Neurol Scand. 2011 doi: 10.1111/j.1600-0404.2011.01505.x.
    
2. Bodzioch M, Lapicka-Bodzioch K, Rudzinska M, Pietrzyk JJ, Bik-Multanowski M, Szczudlik A.
   Severe dystonic encephalopathy without hyperphenylalaninemia associated with an 18-bp deletion within the proximal GCH1 promoter.
   Mov Disord. 2011 Feb 1;26(2):337-40.
    
3. Klimkowicz-Mrowiec A, Furgał M, Słowik A, Szczudlik A.
   Reversible limbic encephalitis in a person with Alzheimer's disease.
   J Am Geriatr Soc. 2011 Apr;59(4):757-9.
    
4. Anderson CD, Biffi A, Rahman R, Ross OA, Jagiella JM, Kissela B, Cole JW, Cortellini L, Rost NS, Cheng YC, Greenberg SM, de Bakker PI, Brown RD Jr, Brott TG, Mitchell BD, Broderick JP, Worrall BB, Furie KL, Kittner SJ, Woo D, Słowik A, Meschia JF, Saxena R, Rosand J; International Stroke Genetics Consortium.
   Common mitochondrial sequence variants in ischemic stroke.
   Ann Neurol. 2011;69(3):471-80.
    
5. Pera J, Korostynski M, Krzyszkowski T, Czopek J, Słowik A, Dziedzic T, Piechota M, Stachura K, Moskala M, Przewłocki R, Szczudlik A.
   Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation?
   Stroke. 2010;41(2):224-31.
    
6. Undas A, Słowik A, Wołkow P, Szczudlik A, Tracz W.
   Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
   Thromb Res. 2010;125(4):357-61.
    
7. Rudzińska M, Wójcik M, Szczudlik A.
   Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
   J Neural Transm. 2010;117(6):765-72.
    
8. Gaweda-Walerych K, Safranow K, Maruszak A, Bialecka M, Klodowska-Duda G, Czyzewski K, Sławek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Kurzawski M, Szczudlik A, Canter JA, Barcikowska M, Zekanowski C.
   Mitochondrial transcription factor A variants and the risk of Parkinson's disease.
   Neurosci Lett. 2010;469(1):24-9.
    
9. Golenia A, Tomik B, Zawiślak D, Wołkow P, Dziubek A, Sado M, Szczudlik A, Figlewicz DA, Słowik A.
   Lack of association between VEGF gene polymorphisms and plasma VEGF levels and sporadic ALS.
   Neurology. 2010;75(22):2035-7.
    
10. Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L, Ayres A, Schwab K, Juchniewicz K, Urbanik A, Rost NS, Viswanathan A, Seifert-Held T, Stoegerer EM, Tomás M, Rabionet R, Estivill X, Brown DL, Silliman SL, Selim M, Worrall BB, Meschia JF, Montaner J, Lindgren A, Roquer J, Schmidt R, Greenberg SM, Słowik A, Broderick JP, Woo D, Rosand J; International Stroke Genetics Consortium.
    Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.
    Ann Neurol. 2010;68(6):934-43.
     
11. Słowik J, Wnuk MA, Grzech K, Golenia A, Turaj W, Ferens A, Jurczak A, Chomyszyn-Gajewska M, Loster B, Słowik A.
    Periodontitis affects neurological deficit in acute stroke.
    J Neurol Sci. 2010;297(1-2):82-4.
     
12. Gissel M, Undas A, Słowik A, Mann KG, Brummel-Ziedins KE.
    Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events.
    Thromb Res. 2010;126(4):262-9.
     
13. Blauw HM, Al-Chalabi A, Andersen PM, van Vught PW, Diekstra FP, van Es MA, Saris CG, Groen EJ, van Rheenen W, Koppers M, Van't Slot R, Strengman E, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Kiemeney LA, Vermeulen SH, Birve A, Waibel S, Meyer T, Cronin S, McLaughlin RL, Hardiman O, Sapp PC, Tobin MD, Wain LV, Tomik B, Słowik A, Lemmens R, Rujescu D, Schulte C, Gasser T, Brown RH Jr, Landers JE, Robberecht W, Ludolph AC, Ophoff RA, Veldink JH, van den Berg LH.
    A large genome scan for rare CNVs in amyotrophic lateral sclerosis.
    Hum Mol Genet. 2010;19(20):4091-9.
     
14. Lemmens R, Buysschaert I, Geelen V, Fernandez-Cadenas I, Montaner J, Schmidt H, Schmidt R, Attia J, Maguire J, Levi C, Jood K, Blomstrand C, Jern C, Wnuk M, Słowik A, Lambrechts D, Thijs V; International Stroke Genetics Consortium.
    The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology.
    Stroke. 2010;41(9):1850-7.
     
15. Taes I, Goris A, Lemmens R, van Es MA, van den Berg LH, Chio A, Traynor BJ, Birve A, Andersen P, Słowik A, Tomik B, Brown RH Jr, Shaw CE, Al-Chalabi A, Boonen S, Van Den Bosch L, Dubois B, Van Damme P, Robberecht W.
    Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.
    Neurology. 2010;74(21):1687-93.
     
16. Klimkowicz-Mrowiec A, Marona M, Wołkow P, Maruszak A, Styczynska M, Barcikowska M, Zekanowski C, Szczudlik A, Słowik A.
    Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
    Dement Geriatr Cogn Disord. 2009;28(5):461-4.
     
17. Turaj W, Słowik A, Wnuk M, Szczudlik A.
    Gender-related differences in diagnostic evaluation and outcome of ischemic stroke in Poland.
    Stroke. 2009;40(3):980-2.
     

Ocena kolejnych segmentów w USG płuc

Bostoński kwestionariusz zespołu cieśni nadgarskta - wersja polska